BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16806415)

  • 21. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
    Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
    Vassilakopoulou M; de la Motte Rouge T; Colin P; Ouzzane A; Khayat D; Dimopoulos MA; Papadimitriou CA; Bamias A; Pignot G; Nouhaud FX; Hurel S; Guy L; Bigot P; Roumiguié M; Rouprêt M;
    Cancer; 2011 Dec; 117(24):5500-8. PubMed ID: 21638278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
    Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
    Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Kuoppala T; Mäenpää J; Tomas E; Puistola U; Salmi T; Grenman S; Lehtovirta P; Fors M; Luukkaala T; Sipilä P
    Gynecol Oncol; 2008 Aug; 110(2):190-5. PubMed ID: 18534669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical review of conservative management of upper urinary tract transitional cell carcinoma].
    Oka H; Shiraishi Y; Negoro H; Iwamura H; Moroi S; Soeda A; Takeuchi H; Kawakita M
    Hinyokika Kiyo; 2006 Apr; 52(4):249-53. PubMed ID: 16686350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
    Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
    Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper urinary tract tumors with nontransitional histology: a single-center experience.
    Busby JE; Brown GA; Tamboli P; Kamat AM; Dinney CP; Grossman HB; Matin SF
    Urology; 2006 Mar; 67(3):518-23. PubMed ID: 16527570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
    Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
    J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
    Lerner SE; Blute ML; Richardson RL; Zincke H
    Mayo Clin Proc; 1996 Oct; 71(10):945-50. PubMed ID: 8820768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.